Literature DB >> 561632

Activation of bovine factor VII by hageman factor fragments.

R Radcliffe, A Bagdasarian, R Colman, Y Nemerson.   

Abstract

During the early events of coagulation of human blood by the intrinsic pathway, factor XII is activated to a form which can activate factor XI, and is proteolytically fragmented to smaller species (30,000 daltons and 70,000 daltons) which have lost most of the ability to activate factor XI but which can activate prekallikrein rapidly. The effect of these fragments on factor VII was studied. It was found that these Hageman factor fragments promoted rapid proteolysis of one-chain factor VII to a more active two-chain form. The amino-terminal sequences of the chains of activated factor VII were found to be Ala-Asx-Gly- and Ile-Val-Gly-, the same as were earlier observed after activation of factor VII by activated factor X. This finding indicates that initiation of coagulation by the intrinsic pathway also primes the extrinsic pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561632

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.

Authors:  M van Geffen; M Cugno; P Lap; A Loof; M Cicardi; W van Heerde
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

Review 4.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.

Authors:  Raheleh Halabian; Mahdi Edalati Fathabad; Nasser Masroori; Amaneh Mohammadi Roushandeh; Sasan Saki; Nasser Amirizadeh; Ali Jahanian Najafabadi; Ahmad Gharehbaghian; Mehryar Habibi Roudkenar
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

6.  A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.

Authors:  Volker Pönitz; José W Govers-Riemslag; Hugo Ten Cate; Rene van Oerle; Trygve Brügger-Andersen; Heidi Grundt; Patrycja Næsgaard; David Pritchard; Alf I Larsen; Dennis W Nilsen
Journal:  Thromb J       Date:  2010-04-15

7.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Authors:  A de Agostini; H R Lijnen; R A Pixley; R W Colman; M Schapira
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Congenital factor VII deficiency. A report of four new cases.

Authors:  R Zimmermann; G Ehlers; W Ehlers; H von Voss; U Göbel; U Wahn
Journal:  Blut       Date:  1979-02-19

9.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.